Personal tools

Coexpression cluster:C513

From FANTOM5_SSTAR

Revision as of 18:05, 12 September 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C513_Tracheal_Bronchial_squamous_bronchial_Small_oral_medulloblastoma



Phase1 CAGE Peaks

Hg19::chr11:70952310..70952311,-p24@SHANK2
Hg19::chr14:90085820..90085840,-p6@FOXN3
Hg19::chr15:76443020..76443024,-p@chr15:76443020..76443024
-
Hg19::chr17:80450992..80450999,+p@chr17:80450992..80450999
+
Hg19::chr1:150254401..150254408,-p@chr1:150254401..150254408
-
Hg19::chr1:185381713..185381720,-p@chr1:185381713..185381720
-
Hg19::chr1:200270929..200270934,-p@chr1:200270929..200270934
-
Hg19::chr1:3591362..3591369,-p@chr1:3591362..3591369
-
Hg19::chr20:6902511..6902515,+p@chr20:6902511..6902515
+
Hg19::chr3:134049971..134049973,-p@chr3:134049971..134049973
-
Hg19::chr3:37262958..37262962,+p@chr3:37262958..37262962
+
Hg19::chr4:44963669..44963674,+p@chr4:44963669..44963674
+
Hg19::chr5:138751193..138751196,-p@chr5:138751193..138751196
-
Hg19::chr5:34599678..34599683,-p@chr5:34599678..34599683
-
Hg19::chr7:46608530..46608534,+p@chr7:46608530..46608534
+
Hg19::chr8:126557025..126557029,+p@chr8:126557025..126557029
+
Hg19::chr8:98941240..98941249,+p@chr8:98941240..98941249
+
Hg19::chr8:99403902..99403910,+p@chr8:99403902..99403910
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0030160GKAP/Homer scaffold activity0.00557297107210372
GO:0000085G2 phase of mitotic cell cycle0.00557297107210372
GO:0051319G2 phase0.00557297107210372
GO:0030159receptor signaling complex scaffold activity0.0167130071253003
GO:0032947protein complex scaffold0.0167130071253003
GO:0000077DNA damage checkpoint0.0167130071253003
GO:0031570DNA integrity checkpoint0.0167130071253003
GO:0042770DNA damage response, signal transduction0.0224531431309998
GO:0000075cell cycle checkpoint0.0259872926223361
GO:0051329interphase of mitotic cell cycle0.0341544880708405
GO:0051325interphase0.0341544880708405



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
endoderm-derived structure1.29e-07169
endoderm1.29e-07169
presumptive endoderm1.29e-07169
respiratory system1.49e-0772
surface structure2.01e-0795
mesenchyme2.59e-07238
entire embryonic mesenchyme2.59e-07238
Disease
Ontology termp-valuen
cancer6.70e-26235
disease of cellular proliferation7.84e-26239
cell type cancer1.39e-23143
carcinoma9.09e-22106
squamous cell carcinoma3.06e-0814
organ system cancer6.44e-08137


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.